Cargando…
Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652544/ http://dx.doi.org/10.1186/2051-1426-3-S2-P429 |
| _version_ | 1782401777266589696 |
|---|---|
| author | Ascarateil, Stephane Puget, Aude Gaucheron, Jerome Koziol, Marie-Eve |
| author_facet | Ascarateil, Stephane Puget, Aude Gaucheron, Jerome Koziol, Marie-Eve |
| author_sort | Ascarateil, Stephane |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4652544 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46525442015-11-25 Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines Ascarateil, Stephane Puget, Aude Gaucheron, Jerome Koziol, Marie-Eve J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652544/ http://dx.doi.org/10.1186/2051-1426-3-S2-P429 Text en Copyright © 2015 Ascarateil et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Ascarateil, Stephane Puget, Aude Gaucheron, Jerome Koziol, Marie-Eve Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title | Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title_full | Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title_fullStr | Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title_full_unstemmed | Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title_short | Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines |
| title_sort | sustained release of actives with montanide™ isa 51 vg and montanide™ isa 720 vg, two adjuvants dedicated to human therapeutic vaccines |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652544/ http://dx.doi.org/10.1186/2051-1426-3-S2-P429 |
| work_keys_str_mv | AT ascarateilstephane sustainedreleaseofactiveswithmontanideisa51vgandmontanideisa720vgtwoadjuvantsdedicatedtohumantherapeuticvaccines AT pugetaude sustainedreleaseofactiveswithmontanideisa51vgandmontanideisa720vgtwoadjuvantsdedicatedtohumantherapeuticvaccines AT gaucheronjerome sustainedreleaseofactiveswithmontanideisa51vgandmontanideisa720vgtwoadjuvantsdedicatedtohumantherapeuticvaccines AT koziolmarieeve sustainedreleaseofactiveswithmontanideisa51vgandmontanideisa720vgtwoadjuvantsdedicatedtohumantherapeuticvaccines |